GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cosmo Pharmaceuticals NV (OTCPK:CMOPF) » Definitions » Dividends per Share

CMOPF (Cosmo Pharmaceuticals NV) Dividends per Share : $0.00 (TTM As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Cosmo Pharmaceuticals NV Dividends per Share?

Cosmo Pharmaceuticals NV's dividends per share for the six months ended in Jun. 2024 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00. Its Dividend Payout Ratio for the six months ended in Jun. 2024 was 0.00. As of today, Cosmo Pharmaceuticals NV's Dividend Yield % is 3.12%.

Good Sign:

Cosmo Pharmaceuticals NV stock dividend yield is close to 10-year high.

During the past 12 months, Cosmo Pharmaceuticals NV's average Dividends Per Share Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Cosmo Pharmaceuticals NV was 13.40% per year. The lowest was 13.40% per year. And the median was 13.40% per year.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Cosmo Pharmaceuticals NV Dividends per Share Historical Data

The historical data trend for Cosmo Pharmaceuticals NV's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmo Pharmaceuticals NV Dividends per Share Chart

Cosmo Pharmaceuticals NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividends per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1.01 1.15

Cosmo Pharmaceuticals NV Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 - 1.14 - -

Competitive Comparison of Cosmo Pharmaceuticals NV's Dividends per Share

For the Drug Manufacturers - General subindustry, Cosmo Pharmaceuticals NV's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cosmo Pharmaceuticals NV's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cosmo Pharmaceuticals NV's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Cosmo Pharmaceuticals NV's Dividend Yield % falls into.



Cosmo Pharmaceuticals NV Dividends per Share Calculation

Dividends paid to per common share.


Cosmo Pharmaceuticals NV  (OTCPK:CMOPF) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Cosmo Pharmaceuticals NV's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2024 )/ EPS without NRI (Q: Jun. 2024 )
=0/ 5.022
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Cosmo Pharmaceuticals NV was 1.10. The lowest was 0.25. And the median was 0.91.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Cosmo Pharmaceuticals NV Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
EUR 2.0000002024-07-102024-07-112024-07-12Cash DividendannuallyEUR:USD 1.081081

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.


Cosmo Pharmaceuticals NV's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=2.162162/69.62
=3.11 %

Current Share Price is $69.62.
Cosmo Pharmaceuticals NV's Dividends per Share for the trailing twelve months (TTM) ended in Today is $2.162162.

During the past 13 years, the highest Dividend Yield of Cosmo Pharmaceuticals NV was 3.12%. The lowest was 0.68%. And the median was 1.32%.

Good Sign:

Cosmo Pharmaceuticals NV stock dividend yield is close to 10-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cosmo Pharmaceuticals NV Dividends per Share Related Terms

Thank you for viewing the detailed overview of Cosmo Pharmaceuticals NV's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cosmo Pharmaceuticals NV Business Description

Traded in Other Exchanges
Address
Sir John Rogerson’s Quay, Riverside II, Dublin, IRL, 2
Cosmo Pharmaceuticals NV is a pharmaceutical company with a focus on gastrointestinal diseases, dermatology and healthtech. The company develops and manufactures products that are distributed globally by its partners. Products that the company has developed include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travellers' diarrhoea (TD) and Winlevi for the treatment of acne. Product pipeline includes Breezula, GI Genius, Methylene blue MMX, Aemcolo, CB-03-10 and CB-01-33.